FIGS, Inc. Q3 2024 10-Q Summary
Business Context and Reporting Period
Company: FIGS, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2024
Business Overview: FIGS is a direct-to-consumer healthcare apparel and lifestyle brand, primarily selling scrubwear and non-scrubwear to healthcare professionals. The company operates a digital platform and physical "Community Hub" retail stores. As of September 30, 2024, the company reported approximately 2.7 million active customers.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 9M 2024 | YTD 9M 2023 |
|---|---|---|---|---|
| Net Revenues | $140.2 million | $142.4 million | $403.7 million | $400.7 million |
| Gross Profit | $94.0 million | $97.4 million | $273.4 million | $279.1 million |
| Gross Margin | 67.1% | 68.4% | 67.7% | 69.6% |
| Operating Income (Loss) | $(8.6) million | $10.0 million | $(6.6) million | $19.8 million |
| Net Income (Loss) | $(1.7) million | $6.1 million | $0.8 million | $12.6 million |
| Adjusted EBITDA | $4.8 million | $24.4 million | $30.7 million | $59.4 million |
| Operating Cash Flow (9M) | $50.7 million (vs. $80.6 million prior year) | |||
| Free Cash Flow (9M) | $37.1 million (vs. $70.9 million prior year) | |||
| Cash & Equivalents | $124.1 million (as of Sept 30, 2024) | |||
| Debt | No outstanding borrowings; $95.1 million available under revolving credit facility. |
Material Changes vs. Prior Period
- Revenue Decline: Q3 net revenues decreased 1.5% year-over-year, driven primarily by a decrease in Average Order Value (AOV) from $114 to $108, partially offset by an increase in orders from existing customers.
- Margin Compression: Gross margin decreased 130 basis points to 67.1% due to higher discounted sales and product mix shifts. Operating expenses increased 17.4% to $102.7 million, largely due to a 50.1% increase in marketing spend (Olympics campaign) and higher fulfillment costs.
- Profitability Shift: The company reported a net loss of $1.7 million in Q3 2024 compared to a net income of $6.1 million in Q3 2023. Adjusted EBITDA margin contracted significantly to 3.4% from 17.2%.
- Share Repurchases: The company initiated a $50.0 million share repurchase program in August 2024. During Q3, it repurchased 1.5 million shares for approximately $7.3 million.
- Investment Activity: In November 2024 (subsequent event), the company invested $25.0 million for a minority interest in OOG, Inc., an AI-powered education platform for healthcare professionals.
Guidance, Outlook, and Risks
- Operational Transition: The company completed a transition of all fulfillment operations to a new facility in Goodyear, Arizona, incurring approximately $2.4 million in capital expenditures during Q3. This transition contributed to higher selling expenses.
- Supply Chain Challenges: Ongoing conflict in the Middle East and a brief East Coast port strike caused shipping delays and elevated freight costs. The company is proactively managing these risks by utilizing alternative routes and air freight.
- Supplier Transition: FIGS is transitioning away from a key third-party supplier in Jordan following allegations of labor conditions that did not meet company standards. This transition may incur additional costs and challenges.
- Legal Proceedings: A putative securities class action and related derivative suits remain pending. The company intends to vigorously defend against these claims but notes potential adverse effects on financial condition if resolved unfavorably.
- Outlook: Management expects operating expenses to increase in absolute dollars as the business grows. The company anticipates seasonality with higher revenues and expenses in the fourth quarter.
Key Investor Verification Points
- Sustainability of Margins: Verify if the gross margin compression (down 1.3 percentage points) is a temporary result of the fulfillment transition and promotional activity or a structural shift due to pricing pressure.
- Marketing Efficiency: Assess the return on the significant increase in marketing spend (up 50% in Q3) and its impact on customer acquisition costs and long-term retention.
- Supplier Diversification: Monitor the progress and cost implications of transitioning away from the Jordanian supplier and the impact on inventory levels and lead times.
- Cash Flow Trajectory: Review the significant year-over-year decline in operating and free cash flow (down ~37% and ~48% respectively for the 9-month period) to ensure liquidity remains sufficient for growth and the new share repurchase program.
- Legal Exposure: Track the status of the pending securities class action litigation and any potential financial impact.